X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (199) 199
Journal Article (147) 147
Conference Proceeding (13) 13
Publication (11) 11
Dissertation (4) 4
Magazine Article (4) 4
Book / eBook (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
performing operations (72) 72
transporting (72) 72
human necessities (60) 60
after-treatment of the shaped products, e.g. repairing (56) 56
shaping of material in a plastic state, not otherwise providedfor (56) 56
shaping or joining of plastics (56) 56
working of plastics (56) 56
working of substances in a plastic state, in general (56) 56
hygiene (47) 47
medical or veterinary science (47) 47
surgery (36) 36
diagnosis (33) 33
identification (32) 32
physics (32) 32
humans (28) 28
animals (26) 26
index medicus (25) 25
chemistry (20) 20
measuring (17) 17
metallurgy (17) 17
testing (17) 17
electricity (16) 16
mice (16) 16
male (15) 15
cell biology (13) 13
general tagging of cross-sectional technologies spanning over several sections of the ipc (12) 12
general tagging of new technological developments (12) 12
parkinson's disease (12) 12
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (12) 12
technologies or applications for mitigation or adaptation againstclimate change (12) 12
agriculture (11) 11
climate change mitigation technologies in the production orprocessing of goods (11) 11
measuring force, stress, torque, work, mechanical power,mechanical efficiency, or fluid pressure (11) 11
animal husbandry (10) 10
artificial respiration (10) 10
bathing devices for special therapeutic or hygienic purposesor specific parts of the body (10) 10
cultivation of vegetables, flowers, rice, fruit, vines, hopsor seaweed (10) 10
fishing (10) 10
forestry (10) 10
horticulture (10) 10
hunting (10) 10
massage (10) 10
mutation (10) 10
mutations (10) 10
physical therapy apparatus, e.g. devices for locating orstimulating reflex points in the body (10) 10
trapping (10) 10
watering (10) 10
basic electric elements (9) 9
biochemistry & molecular biology (9) 9
female (9) 9
organic chemistry (9) 9
oxidative stress (9) 9
research (9) 9
alpha-synuclein (8) 8
blasting (8) 8
heating (8) 8
lighting (8) 8
mechanical engineering (8) 8
rats (8) 8
research article (8) 8
weapons (8) 8
adult (7) 7
apoptosis (7) 7
compositions based thereon (7) 7
fixed constructions (7) 7
mice, knockout (7) 7
organic macromolecular compounds (7) 7
protein (7) 7
their preparation or chemical working-up (7) 7
acyclic or carbocyclic compounds (6) 6
brain - metabolism (6) 6
drosophila (6) 6
hela cells (6) 6
manipulators (6) 6
middle aged (6) 6
nervous system diseases (6) 6
neurodegeneration (6) 6
neurodegenerative diseases (6) 6
neurons - metabolism (6) 6
neurosciences (6) 6
parkin (6) 6
proteins (6) 6
ubiquitin (6) 6
aged (5) 5
autophagy (5) 5
cell line (5) 5
compounds thereof (5) 5
current collectors (5) 5
gene-expression (5) 5
genetics & heredity (5) 5
inorganic chemistry (5) 5
line connectors (5) 5
medicine (5) 5
membrane proteins - genetics (5) 5
mitochondria (5) 5
mitochondria - metabolism (5) 5
multidisciplinary sciences (5) 5
neurology (5) 5
neurons (5) 5
parkinson disease (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Heat and Mass Transfer, ISSN 0017-9310, 02/2020, Volume 148, p. 119024
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2009, Volume 119, Issue 3, pp. 650 - 660
Journal Article
Catalysis Letters, ISSN 1011-372X, 6/2014, Volume 144, Issue 6, pp. 980 - 986
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 11/2016, Volume 53, Issue 9, pp. 5876 - 5892
Recent evidence suggests that nerve growth factor IB (Nur77) and nuclear receptor related1 (Nurr1) are differentially involved in dopaminergic... 
Neurology | Neuroprotection | Neurosciences | Biomedicine | Memantine | Neurobiology | Nurr1 | Nur77 | Inflammation | Parkinson’s disease | Cell Biology | OXIDATIVE STRESS | Parkinson's disease | DOPAMINERGIC-NEURONS | ALPHA-SYNUCLEIN | NEUROSCIENCES | CELL-DEATH | MITOCHONDRIAL TRANSLOCATION | IN-VITRO | GENE-EXPRESSION | NR4A NUCLEAR RECEPTORS | TRANSCRIPTION FACTOR | PARKINSONS-DISEASE | L-Lactate Dehydrogenase - metabolism | Tumor Necrosis Factor-alpha - metabolism | Dopamine Plasma Membrane Transport Proteins - metabolism | Inflammation - pathology | Tyrosine 3-Monooxygenase - metabolism | Oxidopamine | PC12 Cells | Nerve Degeneration - metabolism | Neuroprotection - drug effects | Gene Knockdown Techniques | Inflammation - metabolism | Interleukin-6 - metabolism | Cell Survival - drug effects | Memantine - pharmacology | Cytochromes c - metabolism | Rats | Mitochondria - metabolism | Mitochondria - drug effects | Subcellular Fractions - metabolism | Nerve Degeneration - pathology | Animals | MAP Kinase Signaling System - drug effects | Nuclear Receptor Subfamily 4, Group A, Member 1 - metabolism | Glutamic Acid - metabolism | Nuclear Receptor Subfamily 4, Group A, Member 2 - metabolism | Post-translational modification | Analysis | Nerve growth factor | Nervous system agents | Alzheimer's disease | Alzheimers disease | Neurodegeneration | Parkinsons disease
Journal Article
Cell death & disease, ISSN 2041-4889, 11/2018, Volume 9, Issue 11, pp. 1113 - 14
Cisplatin is a widely used chemotherapeutic drug with notorious toxicity in the kidneys, which involves mitochondrial dysfunction and damage in renal tubular... 
PARKIN | APOPTOSIS | CELLS | MITOCHONDRIAL DYNAMICS | PINK1 | UBIQUITIN | MECHANISMS | AUTOPHAGY | INDUCTION | P53 | CELL BIOLOGY | Protein Kinases - metabolism | Protein Kinases - genetics | TOR Serine-Threonine Kinases - metabolism | Male | Acute Kidney Injury - genetics | Autophagy - drug effects | Kidney Function Tests | TOR Serine-Threonine Kinases - antagonists & inhibitors | Autophagosomes - drug effects | TOR Serine-Threonine Kinases - genetics | Antineoplastic Agents - adverse effects | Acute Kidney Injury - chemically induced | Antineoplastic Agents - pharmacology | Mitophagy - genetics | Autophagy - genetics | Cisplatin - antagonists & inhibitors | Cell Line | Kidney Tubules, Proximal - pathology | Signal Transduction | Acute Kidney Injury - pathology | Mice, Inbred C57BL | Gene Expression Regulation | Ubiquitin-Protein Ligases - metabolism | Mitochondria - metabolism | Autophagosomes - metabolism | Cisplatin - pharmacology | Mitochondria - drug effects | Sirolimus - pharmacology | Acute Kidney Injury - prevention & control | Mice, Knockout | Animals | Mitophagy - drug effects | Kidney Tubules, Proximal - metabolism | Cisplatin - adverse effects | Mice | Ubiquitin-Protein Ligases - genetics | Kidney Tubules, Proximal - drug effects | TOR protein | Cell culture | Animal models | Renal function | Kidneys | Toxicity | Homeostasis | Rapamycin | Autophagy | Cisplatin | Mitochondria | PTEN-induced putative kinase | Rodents | Parkin protein | Phagocytosis | Apoptosis
Journal Article
Cell death & disease, ISSN 2041-4889, 06/2017, Volume 8, Issue 6, p. e2854
Cystatin C (CYS C, Cst3) is an endogenous cysteine protease inhibitor that plays neuroprotective roles in neurodegenerative diseases. We aimed to explore the... 
BIOMARKERS | PATHWAYS | INHIBITION | PROTEIN | DEGRADATION | ALPHA-SYNUCLEIN | CELL | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | DEGENERATION | CELL BIOLOGY | Neovascularization, Physiologic - drug effects | Neurons - pathology | Microtubule-Associated Proteins - genetics | Substantia Nigra - pathology | Microtubule-Associated Proteins - metabolism | Cystatin C - pharmacology | Humans | Caspase 3 - metabolism | Injections, Intraventricular | Vascular Endothelial Growth Factor A - metabolism | Nuclear Receptor Subfamily 4, Group A, Member 2 - genetics | Substantia Nigra - metabolism | Vascular Endothelial Growth Factor A - genetics | PC12 Cells | Autophagy - drug effects | Neuroprotective Agents - pharmacology | Oxidopamine - pharmacology | Caspase 3 - genetics | Chorioallantoic Membrane - drug effects | Neurons - metabolism | Parkinson Disease - metabolism | alpha-Synuclein - genetics | Neurons - drug effects | Chorioallantoic Membrane - blood supply | Disease Models, Animal | Parkinson Disease - pathology | Signal Transduction | Gene Expression Regulation | Rats | Chorioallantoic Membrane - metabolism | Mice, Transgenic | Parkinson Disease - genetics | Chick Embryo | Substantia Nigra - drug effects | Animals | Mice | Nuclear Receptor Subfamily 4, Group A, Member 2 - metabolism | Oxidopamine - antagonists & inhibitors | alpha-Synuclein - metabolism | Cystatin | Neuroprotection | Cysteine | Animal models | Parkinson's disease | Proteinase | Cysteine proteinase | Parkinsons disease | Synuclein | Autophagy | Neuromodulation | Angiogenesis | Neurodegeneration | Transgenic animals | Cystatin C | Vascular endothelial growth factor | Movement disorders | Cell survival | Neurodegenerative diseases | Transgenic mice | 6-Hydroxydopamine | Extracellular signal-regulated kinase | Nuclear receptors | Survival | Nurr1 protein | Chorioallantoic membrane | Phagocytosis | Apoptosis
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2006, Volume 103, Issue 36, pp. 13520 - 13525
Journal Article
The Journal of cell biology, ISSN 0021-9525, 01/2019, Volume 218, Issue 1, pp. 267 - 284
Journal Article
Human Genetics, ISSN 0340-6717, 2/2018, Volume 137, Issue 2, pp. 141 - 150
Reticulon 3 (RTN3) is a neuronally-expressed reticulon family protein that was previously shown to negatively regulate BACE1, a protease that is required for... 
Human Genetics | Gene Function | Molecular Medicine | Biomedicine | Metabolic Diseases | b-Site APP cleaving enzyme 1 | Neurodegenerative diseases | β-Amyloid | Mutation | Axonal transport | Alzheimer's disease | Age | Plaques | Amyloid precursor protein
Journal Article
Catalysis Letters, ISSN 1011-372X, 10/2014, Volume 144, Issue 10, pp. 1766 - 1771
Hydrogenation of levulinic acid (LA) was investigated with several commercial catalysts for the production of γ-valerolactone (GVL). In contrast with other... 
Raney Ni | Chemistry | Levulinic acid | Physical Chemistry | Organometallic Chemistry | Catalysis | Industrial Chemistry/Chemical Engineering | Hydrogenation | γ-Valerolactone | Quenching | TRANSFORMATION | gamma-Valerolactone | LIQUID | CHEMISTRY, PHYSICAL | ETHYL LEVULINATE | SKELETAL NI | SELECTIVE HYDROGENATION | AQUEOUS-PHASE | CHEMICALS | BIOMASS | CELLULOSE | FUELS | Catalysts | Nickel | Selectivity | Noble metals | Conversion
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 08/2014, Volume 51, Issue 8, pp. 518 - 525
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e81884
Journal Article